BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaffe E, Magkrioti C, Aidinis V. Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer. Cancers (Basel) 2019;11:E1626. [PMID: 31652837 DOI: 10.3390/cancers11111626] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Shidoji Y, Iwao C. A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis. Biochem Biophys Rep 2021;28:101176. [PMID: 34869922 DOI: 10.1016/j.bbrep.2021.101176] [Reference Citation Analysis]
2 Borza R, Salgado-Polo F, Moolenaar WH, Perrakis A. Structure and function of the Ecto-Nucleotide Pyrophosphatase-Phosphodiesterase (ENPP) family: tidying up diversity. J Biol Chem 2021;:101526. [PMID: 34958798 DOI: 10.1016/j.jbc.2021.101526] [Reference Citation Analysis]
3 Brindley DN. Lysophosphatidic Acid Signaling in Cancer. Cancers (Basel) 2020;12:E3791. [PMID: 33339127 DOI: 10.3390/cancers12123791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Wen Tan SL, Israeli E, Ericksen RE, Chow PK, Han W. The altered lipidome of hepatocellular carcinoma. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.02.004] [Reference Citation Analysis]
5 Du C, Quan S, Nan X, Zhao Y, Shi F, Luo Q, Xiong B. Effects of oral milk extracellular vesicles on the gut microbiome and serum metabolome in mice. Food Funct 2021;12:10938-49. [PMID: 34647936 DOI: 10.1039/d1fo02255e] [Reference Citation Analysis]
6 Cabrera-Reyes F, Parra-Ruiz C, Yuseff MI, Zanlungo S. Alterations in Lysosome Homeostasis in Lipid-Related Disorders: Impact on Metabolic Tissues and Immune Cells. Front Cell Dev Biol 2021;9:790568. [PMID: 34957117 DOI: 10.3389/fcell.2021.790568] [Reference Citation Analysis]
7 Gao S, Gang J, Yu M, Xin G, Tan H. Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer. BMC Cancer 2021;21:791. [PMID: 34238253 DOI: 10.1186/s12885-021-08520-1] [Reference Citation Analysis]
8 Li Z, Sun C, Qin Z. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming. Theranostics 2021;11:8322-36. [PMID: 34373744 DOI: 10.7150/thno.62378] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
9 Cai R, Lu Q, Wang D. Construction and prognostic analysis of miRNA-mRNA regulatory network in liver metastasis from colorectal cancer. World J Surg Oncol 2021;19:7. [PMID: 33397428 DOI: 10.1186/s12957-020-02107-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
10 Tigyi G, Lin KH, Jang IH, Lee SC. Revisiting the role of lysophosphatidic acid in stem cell biology. Exp Biol Med (Maywood) 2021;246:1802-9. [PMID: 34038224 DOI: 10.1177/15353702211019283] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Han T, Zhang H, Xu W, Li C, Wang M, Bai Y, Yang L, Zhang S, Jia Z, Xu X, Zhao C, Wei F, Li X. Study on the Mechanism of Reducing Hepatotoxicity of Water-Grinding Realgar by Metabolomics, Morphology, and Chemical Analysis. Evid Based Complement Alternat Med 2021;2021:8538287. [PMID: 34950217 DOI: 10.1155/2021/8538287] [Reference Citation Analysis]
12 Voropaeva AE, Mitsura VM, Zaporovannyi YB, Mosunova EA; Gomel State Medical University, Gomel State Medical University, Gomel Regional Medical and Rehabilitation Expert Commission, Gomel State Medical University. PRIMARY DISABILITY DUE TO LIVER CIRROSIS IN THE GOMEL REGION. Hepatol Gastroenterol 2019;3:151-5. [DOI: 10.25298/2616-5546-2019-3-2-151-155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Flores-López M, García-Marchena N, Pavon FJ, Lara E, Porras-Perales O, Araos P, Requena-Ocaña N, Torres-Galván S, Mañas-Padilla MC, Rubio G, Suárez J, Santín LJ, Rodríguez de Fonseca F, Castilla-Ortega E, García-Fernández MI, Serrano A. Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease. Biomedicines 2021;9:1207. [PMID: 34572393 DOI: 10.3390/biomedicines9091207] [Reference Citation Analysis]
14 Gonzalez E, Azkargorta M, Garcia-Vallicrosa C, Prieto-Elordui J, Elortza F, Blanco-Sampascual S, Falcon-Perez JM. Could protein content of Urinary Extracellular Vesicles be useful to detect Cirrhosis in Alcoholic Liver Disease? Int J Biol Sci 2021;17:1864-77. [PMID: 34131392 DOI: 10.7150/ijbs.59725] [Reference Citation Analysis]
15 Li Y, Zhang L, Xu T, Zhao X, Jiang X, Xiao F, Sun H, Wang L. Aberrant ENPP2 expression promotes tumor progression in multiple myeloma. Leuk Lymphoma 2021;:1-12. [PMID: 34847837 DOI: 10.1080/10428194.2021.2010055] [Reference Citation Analysis]
16 Kostadinova L, Shive CL, Anthony DD. Elevated Autotaxin and LPA Levels During Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation. Cancers (Basel) 2019;11:E1867. [PMID: 31769428 DOI: 10.3390/cancers11121867] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
17 Balijepalli P, Sitton CC, Meier KE. Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special? Cells 2021;10:2059. [PMID: 34440828 DOI: 10.3390/cells10082059] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Liu X, Peng Y, Wang J. Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers. Biosci Rep 2020;40:BSR20201053. [PMID: 32412047 DOI: 10.1042/BSR20201053] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Jia Y, Li Y, Xu XD, Tian Y, Shang H. Design and Development of Autotaxin Inhibitors. Pharmaceuticals (Basel) 2021;14:1203. [PMID: 34832985 DOI: 10.3390/ph14111203] [Reference Citation Analysis]
20 Weng J, Zhou C, Zhou Q, Chen W, Yin Y, Atyah M, Dong Q, Shi Y, Ren N. Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:193-209. [PMID: 33824863 DOI: 10.2147/JHC.S300633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]